Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

based on acceleration signals obtained through an intelligent tire sensor attached inside the tire. Moreover, a time series data augmentation method is applied to ensure that the learning network has ...

This configuration will log sensor_accel 0 at full rate ... The table below shows the mean sequential write speed [KB/s] / maximum write time per block (average) [ms] for F4- (Pixracer), F7-, and ...

May 1, 2025 — While exploring a digitally represented object through artificially created sense of touch, brain-computer interface users described the warm fur of a purring cat, the smooth rigid ...